AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Approval of CRISPR Gene Editing Medicine for Sickle Cell Disease
This chapter discusses the approval of a new medicine, Cass Jevy, developed through CRISPR gene editing technology, for the treatment of sickle cell disease. It explores the significance of this development and explains the treatment process for patients.